MX342293B - Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso. - Google Patents

Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.

Info

Publication number
MX342293B
MX342293B MX2012015177A MX2012015177A MX342293B MX 342293 B MX342293 B MX 342293B MX 2012015177 A MX2012015177 A MX 2012015177A MX 2012015177 A MX2012015177 A MX 2012015177A MX 342293 B MX342293 B MX 342293B
Authority
MX
Mexico
Prior art keywords
present
bioactive
relates
mammal
theacea
Prior art date
Application number
MX2012015177A
Other languages
English (en)
Inventor
Koganov Michael
Original Assignee
Akzo Nobel Surface Chemistry Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Surface Chemistry Llc filed Critical Akzo Nobel Surface Chemistry Llc
Publication of MX342293B publication Critical patent/MX342293B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • C01G23/053—Producing by wet processes, e.g. hydrolysing titanium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B13/00—Oxygen; Ozone; Oxides or hydroxides in general
    • C01B13/14—Methods for preparing oxides or hydroxides in general
    • C01B13/32—Methods for preparing oxides or hydroxides in general by oxidation or hydrolysis of elements or compounds in the liquid or solid state or in non-aqueous solution, e.g. sol-gel process
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/36—Compounds of titanium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una fracción biocactiva de una planta Camellia para usarse en la inhibición de actividad inflamatoria en tejido cutáneo de un mamífero, o para usarse en la protección de tejido cutáneo de un mamífero de daño inducido por luz ultravioleta, o para usarse en la normalización de trastornos cutáneos en tejido cutáneo de un mamífero, al aplicar la fracción bioactiva al tejido cutáneo de mamífero, en donde la fracción bioactiva ha sido aislada de la planta Camellia por las etapas de: proporcionar una biomasa fresca de planta Camellia, en donde la biomasa fresca es biomasa de planta Camellia fresca que no ha experimentado procesamiento de té convencional; triturar, macerar y presionar la biomasa fresca de la planta Camellia para separar la biomasa fresca en un jugo celular y componentes de pared celular; someter el jugo celular al tratamiento de microondas para inducir coagulación, con lo que se obtiene una fracción de membrana coagulada y un jugo celular no coagulado; y aislar la fracción bioactiva de la fracción de membrana coagulada, en donde la fracción bioactiva es la fracción de membrana o un extracto de fracción de membrana, en donde la fracción de membrana se aísla al separar la fracción de membrana coagulada del jugo celular no coagulado utilizando centrifugación y, en donde el extracto de fracción de membrana se aísla al someter la fracción de membrana a extracción de solvente con sulfóxido de dimetilo y después centrifugación para obtener un sobrenadante que comprende el extracto de fracción de membrana.
MX2012015177A 2004-01-12 2006-07-11 Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso. MX342293B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53586104P 2004-01-12 2004-01-12

Publications (1)

Publication Number Publication Date
MX342293B true MX342293B (es) 2016-09-23

Family

ID=34806966

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA06007942A MXPA06007942A (es) 2004-01-12 2005-01-12 Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.
MX2012015177A MX342293B (es) 2004-01-12 2006-07-11 Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA06007942A MXPA06007942A (es) 2004-01-12 2005-01-12 Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.

Country Status (14)

Country Link
US (6) US7473435B2 (es)
EP (2) EP1722805B1 (es)
JP (2) JP5276270B2 (es)
KR (1) KR101224697B1 (es)
CN (2) CN1929851B (es)
AU (2) AU2005206875B2 (es)
BR (1) BRPI0506751B8 (es)
CA (1) CA2552710A1 (es)
ES (2) ES2465949T3 (es)
HK (1) HK1098675A1 (es)
MX (2) MXPA06007942A (es)
NZ (2) NZ598539A (es)
PL (1) PL1722805T3 (es)
WO (1) WO2005069835A2 (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277852B2 (en) * 2002-01-25 2012-10-02 Akzo Nobel Surface Chemistry Llc Bioactive botanical cosmetic compositions and processes for their production
EP1991242B1 (en) * 2006-02-21 2017-04-26 Isp Investment Inc. Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
CN101743296B (zh) * 2007-07-13 2014-05-14 小川香料株式会社 香味或香气的劣化抑制剂
DE602008005639D1 (de) * 2007-11-05 2011-04-28 Unilever Nv Verfahren zur isolierung von verbindungen aus tee
PT2222181E (pt) * 2007-11-05 2011-12-22 Unilever Nv Processo para fabricar produtos de chá e produtos que podem ser obtidos a partir do mesmo
WO2009059924A1 (en) * 2007-11-05 2009-05-14 Unilever Plc Process for manufacturing tea products
US20090202676A1 (en) * 2008-02-07 2009-08-13 Conopco, Inc. D/B/A Unilever Process for manufacturing a tea product
EA020611B1 (ru) * 2008-10-02 2014-12-30 Унилевер Н.В. Способ получения чайного продукта, чайный продукт и оздоравливающая композиция
EA020639B1 (ru) * 2008-10-02 2014-12-30 Унилевер Н.В. Способ производства чайных продуктов
JP5287524B2 (ja) * 2009-06-05 2013-09-11 東京電力株式会社 植物系バイオマスの多元的有効利用システム
CN107365709A (zh) * 2009-11-11 2017-11-21 Isp 投资有限责任公司 来自应激诱导的光合生物的生物活性级分及其制备和使用方法
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
CN103221095B (zh) 2010-08-19 2017-02-08 强生消费者公司 治疗蜂窝炎的方法
US9173913B2 (en) 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US20120201768A1 (en) * 2010-09-10 2012-08-09 Cheri Lynn Swanson Cosmetic compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation
US8895628B2 (en) 2010-10-25 2014-11-25 Johnson & Johnson Consumer Companies, Inc. Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
US8293293B2 (en) 2010-12-17 2012-10-23 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium martagon extracts and uses thereof
US9492492B2 (en) 2010-12-17 2016-11-15 Johnson & Johnson Consumer Inc. Compositions comprising Lilium martagon extracts and uses thereof
US8486466B2 (en) 2010-12-17 2013-07-16 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium siberia extracts and uses thereof
US8481093B2 (en) * 2010-12-17 2013-07-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium candidum extracts and uses thereof
EP2465489B1 (en) 2010-12-17 2018-08-22 Johnson & Johnson Consumer Inc. Compositions comprising lilium martagon extracts and uses thereof
EP2465490A3 (en) 2010-12-17 2015-06-17 Johnson & Johnson Consumer Companies Inc. Compositions comprising Lilium Siberia extracts and uses thereof
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
EP2465518B1 (en) 2010-12-17 2016-03-02 Johnson & Johnson Consumer Companies Inc. Compositions Comprising Lilium Candidum Extracts and Uses Thereof
US20130149359A1 (en) * 2011-12-12 2013-06-13 Eric M. Sanders Effervescent Mouthwash
WO2013092699A2 (en) 2011-12-22 2013-06-27 Akzo Nobel Chemicals International B.V. Bioactive compositions having skin anti-aging activity
WO2013096611A2 (en) * 2011-12-22 2013-06-27 The Procter & Gamble Company Compositions and methods for improving the appearance of aging hair
JP5877456B2 (ja) 2011-12-22 2016-03-08 アイエスピー インヴェストメンツ インコーポレイテッドＩｓｐ Ｉｎｖｅｓｔｍｅｎｔｓ Ｉｎｃ． 毛髪抗老化活性を有する生物活性組成物
WO2013096736A2 (en) * 2011-12-22 2013-06-27 The Procter & Gamble Company Compositions and methods for treating skin
US9814659B2 (en) 2012-04-02 2017-11-14 Johnson & Johnson Consumer Inc. Methods of lightening the skin
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
CN104768534B (zh) * 2012-11-14 2017-10-31 阿克佐诺贝尔化学国际公司 制备生物活性植物组合物的方法和由该方法制得的组合物
KR101474998B1 (ko) * 2012-11-28 2014-12-19 롯데푸드 주식회사 피부 주름 생성 억제 및 주름 개선 활성을 갖는 백차 추출물을 함유하는 조성물
SG11201506037WA (en) * 2013-02-08 2015-08-28 Akzo Nobel Chemicals Int Bv Bioactive compositions from theacea plants and use thereof in beverages, functional foods, nutriceuticals, supplements and the like
BR112015020178A2 (pt) * 2013-03-13 2017-07-18 Akzo Nobel Chemicals Int Bv composição com propriedades de inflamação reduzidas para pele biológica e método de redução da inflamação do tecido biológico
US20160008265A1 (en) * 2013-03-14 2016-01-14 Avon Products, Inc Eurya groffii extracts and methods of use
US9579278B2 (en) 2013-05-10 2017-02-28 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba
EP2996775A1 (en) 2013-05-16 2016-03-23 The Procter & Gamble Company Hair thickening compositions and methods of use
EP2829303A1 (en) 2013-07-22 2015-01-28 Johnson & Johnson Consumer Companies Inc. Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta
US9522168B2 (en) 2014-05-29 2016-12-20 Johnson & Johnson Consumer Inc. Topical compositions comprising Acmella oleracea extracts and uses thereof
WO2016016515A1 (fr) * 2014-08-01 2016-02-04 Chanel Parfums Beaute Extrait de camellia japonica et compositions cosmétiques le comprenant
CN107532220A (zh) * 2015-04-07 2018-01-02 希乐克公司 用于处理生物质的监测方法和系统
CN106691902B (zh) 2015-08-14 2021-04-20 强生消费者公司 包含显齿蛇葡萄和合欢提取物的组合物和使用方法
EP3386525B1 (en) * 2015-12-08 2022-02-16 ISP Investments LLC Bioactive compositions from achachairu (garcinia humilis) and methods for their production
KR101723526B1 (ko) * 2016-02-22 2017-04-06 주식회사 젠퓨어 동백꽃, 벚꽃, 쟈스민꽃, 캐모마일꽃 및 연꽃 혼합추출물을 함유하는 화장료 조성물
JP2019506436A (ja) * 2016-02-25 2019-03-07 アイエスピー インヴェストメンツ エルエルシー 生きた植物から得られる原料による日光の悪影響の軽減
KR101769110B1 (ko) 2016-02-29 2017-08-17 전라남도 난대 산림수종의 산림욕 성분의 최적 추출 방법 및 그에 따라 제조된 난대 산림수종의 향기 추출물
CN109689026B (zh) 2016-09-07 2022-08-30 Isp投资有限公司 使用包含生物活性莲提取物的组合物增加脂肪分解的方法
US10204847B2 (en) 2016-10-06 2019-02-12 Infineon Technologies Americas Corp. Multi-phase common contact package
US10056362B2 (en) 2016-10-06 2018-08-21 Infineon Technologies Americas Corp. Multi-phase power converter with common connections
CN107227289B (zh) * 2017-05-08 2020-05-22 广州赛莱拉干细胞科技股份有限公司 一种山茶花细胞提取物及其提取方法和应用
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
AU2019311848A1 (en) 2018-07-27 2021-01-21 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2020021477A2 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824895A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US20210299203A1 (en) 2020-03-26 2021-09-30 Johnson & Johnson Consumer Inc. Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same
AU2021240478A1 (en) 2020-03-26 2022-10-20 Johnson & Johnson Consumer Inc. Compositions comprising Carum carvi and Rosmarinus officinalis extracts and methods of using same
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract
FR3130619A1 (fr) 2021-12-17 2023-06-23 L V M H Recherche Fraction bioactive isolée de roses de la variété Evanrat
WO2023114279A1 (en) 2021-12-17 2023-06-22 Isp Investments Llc Bioactive serum fractions from fresh rose flowers and methods for their preparation and uses
FR3136172A1 (fr) 2022-06-07 2023-12-08 L V M H Recherche Composition anti-âge avec extraits de rose et peptides
FR3137836A1 (fr) 2022-07-13 2024-01-19 L V M H Recherche Fraction bioactive isolée de roses de la variété Evanrat pour une utilisation cosmétique apaisante de la peau et/ou des lèvres

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US255945A (en) * 1882-04-04 James denton
US1072666A (en) * 1912-08-07 1913-09-09 Frank Smith Nut-lock.
US2559459A (en) 1949-02-01 1951-07-03 Western Condensing Co Vegetable treatment process
US3849391A (en) 1969-02-17 1974-11-19 Grain Processing Corp Recovery of protein
US3684520A (en) 1969-12-09 1972-08-15 Us Agriculture Fractionation of leafy green crops
US3821346A (en) 1971-08-02 1974-06-28 W Batley Pet litter produced by recycled molasses serum
US3775133A (en) 1971-08-02 1973-11-27 W Batley Fractionation of alfalfa wetted with molasses serum
US3799806A (en) 1972-04-20 1974-03-26 Danske Sukkerfab Process for the purification and clarification of sugar juices,involving ultrafiltration
US3823128A (en) * 1972-05-16 1974-07-09 Us Agriculture Preparation of edible protein from leafy green crops such as alfalfa
US3959246A (en) 1974-07-08 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Preparation of soluble edible protein from leafy green crops
US4006078A (en) 1974-07-08 1977-02-01 The United States Of America As Represented By The Secretary Of Agriculture Preparation of soluble edible protein from leafy green crops
FR2294647A1 (fr) 1974-11-04 1976-07-16 France Luzerne Procede de traitement de vegetaux verts feuillus en vue d'une extraction de proteines dans les jus de pressage et d'une deshydratation economique du tourteau
GB1430566A (en) 1974-11-15 1976-03-31 Nestel Sa Isolation of proteins
US3993794A (en) 1976-01-15 1976-11-23 The United States Of America As Represented By The Secretary Of Agriculture Method for texturizing proteins
HU174943B (hu) 1976-06-30 1980-04-28 Vepex Foevallalkozasi Iroda Rt Sposob poluchenija koncentratov rastitel'nogo belka i pigmenta
US4077950A (en) 1976-07-12 1978-03-07 Source Proteins, Inc. Process for the recovery of substantially water-soluble non-toxic protein compounds from fresh non-woody vegetation
US4250197A (en) 1976-10-25 1981-02-10 Vepex Fovallalkopasi Iroda Rt. Method for processing plant protein
US4130553A (en) 1977-01-05 1978-12-19 Batley Jr William R Process for improving the nutritional value of green plant protein
CA1099576A (en) 1978-03-23 1981-04-21 Chester D. Myers Improved process for isolation of proteins
DE2816474A1 (de) * 1978-04-15 1979-10-25 Bayer Ag Dichlorbenzodioxolderivate, verfahren zu ihrer herstellung und ihre verwendung als synergisten in insektiziden und akariziden mitteln
US4234620A (en) 1978-12-26 1980-11-18 A. E. Staley Manufacturing Company Water-soluble vegetable protein aggregates
GB2054343B (en) 1979-07-20 1983-08-24 Energiagazdalkodasi Intezet Preserving green vegetable matter
US4347324A (en) 1979-09-24 1982-08-31 Leaf Proteins, Inc. Process for isolation of proteins from plant leaves
WO1982000569A1 (en) 1980-08-13 1982-03-04 Verniers C Method for obtaining clear vegetable juices and for the recovery of valorizable constituents
US4359530A (en) 1980-09-08 1982-11-16 Aluminum Company Of America Protein extraction from green crops
US4334024A (en) 1980-11-03 1982-06-08 Sarjit Johal Preparation and crystallization of fraction I protein from plant sources
JPS5914451B2 (ja) 1981-03-09 1984-04-04 日本薬品開発株式会社 植物緑葉源抗炎症剤
US4333871A (en) 1981-03-18 1982-06-08 International Harvester Company Coagulation method for preparing leaf protein concentrates (LPC) from plant foliage
US4421682A (en) 1981-04-06 1983-12-20 The United States Of America As Represented By The Secretary Of Agriculture Heating of proteinaceous liquids
FR2523976B1 (fr) 1982-03-26 1985-08-30 Pasteur Institut Nouveau produit proteique, obtention et application comme medicament, en particulier immunoregulateur et antiallergique
JPS59130173A (ja) * 1983-01-14 1984-07-26 Shiraimatsu Shinyaku Kk 飲料
SU1194361A1 (ru) * 1983-06-07 1985-11-30 Всесоюзный Научно-Исследовательский Институт Чайной Промышленности Способ производства ча
US4639375A (en) * 1983-08-12 1987-01-27 The Procter & Gamble Company Enzymatic treatment of black tea leaf
US4588691A (en) 1984-02-29 1986-05-13 Johal Sarjit S Method for preparation of Fraction I protein and by-products thereof
US4897346A (en) * 1986-07-15 1990-01-30 Beckman Instruments, Inc. Stabilized liquid enzyme composition for glucose determination
CH671322A5 (es) 1986-09-29 1989-08-31 Bucher Guyer Ag Masch
US4897345A (en) 1987-07-20 1990-01-30 Lubrizol Genetics Inc. Pollen tube growth assay
CN1039525A (zh) * 1988-05-19 1990-02-14 浙江农业大学 速溶茶加工工艺
FR2632308B1 (fr) 1988-06-07 1991-08-16 Fondation Nale Transfusion San Procede et installation de fractionnement en continu de proteines vegetales animales ou humaines
JPH111686A (ja) 1990-05-14 1999-01-06 Yoshihide Hagiwara 抗酸化剤
US5723149A (en) 1990-11-21 1998-03-03 Lvmh Recherche Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
US5798446A (en) 1991-10-10 1998-08-25 Nupron Gmbh Proteinwerk Method of extracting proteins utilizable in foodstuff from a protein-containing substance
JPH05229921A (ja) 1992-02-21 1993-09-07 Nakano Vinegar Co Ltd 発毛促進用組成物
JPH07112404B2 (ja) * 1992-05-08 1995-12-06 協同組合ティーライフクリエイティブ 緑茶の製茶方法
CH684924A5 (de) 1993-04-02 1995-02-15 Bucher Guyer Ag Masch Verfahren zum Trennen fester und flüssiger Anteile, sowie Vorrichtung zu dessen Durchführung.
US5433968A (en) 1993-04-23 1995-07-18 Nestec S.A. Process for producing a simulated meat product
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
US5777080A (en) 1994-05-09 1998-07-07 The Board Of Trustees Of The University Of Arkansas Highly soluble protein, method for making, and food products made thereof
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
AR002779A1 (es) 1995-07-10 1998-04-29 Nestle Sa Procedimiento para fabricar una leche de almendras de frutas.
JPH09202726A (ja) * 1996-01-23 1997-08-05 Shiga Yoko 緑茶浴用剤
US5952023A (en) * 1996-02-05 1999-09-14 Lipton, Division Of Conopco, Inc. Enzyme extraction process for tea
CN1144652A (zh) * 1996-06-28 1997-03-12 青岛医学院附属专科医院 茶叶面膜
FR2751878B1 (fr) 1996-07-30 1998-09-04 Oreal Utilisation dans une composition d'un extrait d'au moins une labiee
KR100639538B1 (ko) 1996-08-02 2007-03-02 가부시키가이샤 시세이도 히알루론산의생산능증강용조성물및이의제조방법
IT1288257B1 (it) 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
US6037456A (en) 1998-03-10 2000-03-14 Biosource Technologies, Inc. Process for isolating and purifying viruses, soluble proteins and peptides from plant sources
US5994508A (en) 1998-04-13 1999-11-30 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
US6013771A (en) 1998-06-09 2000-01-11 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
IT1301871B1 (it) * 1998-07-24 2000-07-07 Marlegreen Holding S A Procedimento per la produzione di te' in polvere o in foglia a ridotticosti di manodopera e di impianto
ES2181113T3 (es) 1998-11-19 2003-02-16 Isernhagen Heilmittelbetr Gmbh Empleo de extractos de salvia, obtenidos por extraccion con dioxido de carbono, como desodorantes.
KR20000033083A (ko) * 1998-11-19 2000-06-15 윤종용 컨버전스 조정장치 및 이에 적합한 컨버전스 조정방법
US6428818B1 (en) * 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
US6610749B2 (en) * 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
KR20010112817A (ko) * 2000-06-15 2001-12-22 황재관 녹차의 생리활성물질 분리방법
US6616952B1 (en) 2000-11-17 2003-09-09 Roseberg Investments, Inc. Organic fungicide
KR100384308B1 (ko) * 2001-02-12 2003-05-14 노일섭 즉석 분말 인삼녹차 및 그 제조방법
KR100395464B1 (ko) * 2001-02-12 2003-08-25 노일섭 카테킨류의 신규한 추출방법 및 이를 이용한 카테킨 함유음료
JP4160276B2 (ja) * 2001-06-12 2008-10-01 株式会社 伊藤園 尿酸値低下剤及び尿酸値低下効果を備えた飲食物
CA2451844A1 (en) * 2001-06-27 2003-01-09 Unigen Pharmaceuticals, Inc. Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents
JP2003024010A (ja) * 2001-07-10 2003-01-28 Kenko Seikagaku:Kk 緑茶カテキンを主成分とする機能強化補助食品
KR20030030332A (ko) * 2001-10-09 2003-04-18 제주대학교 우묵사스레피의 추출물을 포함하는 항암용 조성물
JP2003171297A (ja) * 2001-12-07 2003-06-17 Ito En Ltd 血中ビリルビン濃度低下剤及び黄疸治療・予防剤
JP2003212771A (ja) * 2002-01-23 2003-07-30 Taiyo Kagaku Co Ltd 抗ナイセリア菌組成物
US7442391B2 (en) 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
JP3590032B2 (ja) * 2002-04-17 2004-11-17 花王株式会社 緑茶ポリフェノールの製造法
WO2004080380A2 (fr) * 2003-03-05 2004-09-23 L'oreal Utilisation de polyphenols catechniques pour la preparation de compositions destinees a favoriser la pigmentation naturelle de la peau

Also Published As

Publication number Publication date
AU2005206875A1 (en) 2005-08-04
BRPI0506751B8 (pt) 2021-05-25
EP1722805A2 (en) 2006-11-22
ES2465949T3 (es) 2014-06-09
EP1722805A4 (en) 2009-08-26
CN1929851B (zh) 2012-06-27
US10004777B2 (en) 2018-06-26
EP2491939A1 (en) 2012-08-29
AU2005206875B2 (en) 2010-06-24
CN102327391A (zh) 2012-01-25
US7473435B2 (en) 2009-01-06
NZ598539A (en) 2013-09-27
US8318220B2 (en) 2012-11-27
US20130146481A1 (en) 2013-06-13
WO2005069835A3 (en) 2006-01-12
PL1722805T3 (pl) 2014-08-29
HK1098675A1 (en) 2007-07-27
JP5875896B2 (ja) 2016-03-02
EP1722805B1 (en) 2014-03-26
US8043635B2 (en) 2011-10-25
KR101224697B1 (ko) 2013-01-21
ES2652603T3 (es) 2018-02-05
US20120045404A1 (en) 2012-02-23
AU2010221784A1 (en) 2010-10-07
CN1929851A (zh) 2007-03-14
JP2012136547A (ja) 2012-07-19
KR20060130176A (ko) 2006-12-18
NZ548718A (en) 2011-03-31
MXPA06007942A (es) 2007-02-16
EP2491939B1 (en) 2017-09-20
US20120041059A1 (en) 2012-02-16
BRPI0506751B1 (pt) 2019-12-31
WO2005069835A2 (en) 2005-08-04
US20050181079A1 (en) 2005-08-18
US20140242009A1 (en) 2014-08-28
CN102327391B (zh) 2015-04-22
JP2007517907A (ja) 2007-07-05
US20090185990A1 (en) 2009-07-23
JP5276270B2 (ja) 2013-08-28
BRPI0506751A (pt) 2007-06-12
CA2552710A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
MX342293B (es) Composiciones bioactivas de plantas de theacea y procesos para su produccion y uso.
WO2006075330A3 (en) Methods and pharmaceutical compositions useful for treating psoriasis
WO2009036059A3 (en) Novel stat3 pathway inhibitors and cancer stem cell inhibitors
DK1768500T3 (da) Sammensætninger egnet til behandling af kutane tegn på aldring
WO2009151302A3 (ko) 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물
MX2012000708A (es) Inhibidores de cinasa que regulan la señal de apoptosis.
WO2006127525A3 (en) Proteasome inhibitors and uses thereof
NO20061194L (no) Mitotiske kinesininbibitorer
WO2007142755A3 (en) Purine analogs
EP3718560A3 (en) Cyclin dependent kinase inhibitors and methods of use
WO2006071960A3 (en) Compositions and methods of treating cell proliferation disorders
PL2397156T3 (pl) Sposoby i kompozycje do leczenia uporczywych infekcji i nowotworu poprzez hamowanie ścieżki zaprogramowanej śmierci komórki 1 (PD-1)
WO2006136357A3 (de) Kristalline modifikationen des pyraclostrobins
BRPI0606328B8 (pt) uso de um glicosídeo fenilpropanóide proveniente de uma planta de ajuga reptans, uso de um homogenato de células inteiras de ajuga reptans, uso de um extrato purificado de ajuga reptans e uso de fenilpropanóides provenientes de uma planta ajuga reptans
GB0421900D0 (en) Inhibition of tumour cell migration
WO2009039218A3 (en) Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts
WO2007017176A8 (en) Wound-healing composition
MXPA06002456A (es) Formulacion de una mezcla de flavonoides con el aniillo b libre y flavanos para utilizarse en la prevencion y tratamiento de la declinacion cognoscitiva y el deterioro de la memoria relacionado con la edad.
MX2015010328A (es) Composiciones bioactivas a partir de plantas theacea y uso de las mismas en bebidas, alimentos funcionales, productos nutraceuticos, complementos y similares.
EP2335712A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF LIVER DISEASES CONTAINING VEGETABLE STEM CELL LINES DERIVED FROM PANAX GINSENG CAMBIUM COMPRISING MOUNTAIN GINSENG OR GINSENG AS ACTIVE INGREDIENT
WO2004064719A3 (en) Synergistic compositions and methods for potentiating anti-oxidative activity
UA104994C2 (uk) Придатна для розпилення композиція, що містить екстракт із листя червоного винограду
WO2007008652A3 (en) Methods and compositions directed to dj-1 as regulator of the anti-oxidant transcription factor nrf2
IL172389A0 (en) Compositions and methods for regulating polysaccharides of plant cells
WO2007015175A3 (en) Use of pp-1 inhibitors to prevent missplicing events